Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05417191
Other study ID # 25/07/2012
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2012
Est. completion date February 28, 2014

Study information

Verified date June 2022
Source Harokopio University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The trial was a double-blind randomized dietary intervention study with a 1:1 allocation ratio, conducted in accordance with the Declaration of Helsinki. This study compared two treatments, i.e., farmed fish fed with olive pomace enriched diet (enriched fish; EF) versus farmed fish fed with fish oil diet (conventional fish; CF), using a crossover design. The study lasted 22 weeks; treatment period one (8 weeks, mid-January-end of March), washout period (6 weeks), and treatment period two (8 weeks, mid-May-end of July). The participants were equally distributed to the two treatments along treatment periods. Eligible subjects were all adults aged between 30 and 65 years old with a body mass index (BMI) between 24.0 and 31.0 kg/m2 who met the eligibility criteria for habitual fish consumption (<150 g of cooked fish per week). Exclusion criteria were pregnancy, current or recent weight loss effort, use of dietary supplements and being under treatment for any medical disorder. Subjects were allowed to use medical treatment for thyroid gland disorders, iron or folic acid supplements, contraceptives or hormone replacement therapy (HRT) for women, provided they would continue receiving their medication throughout the study. The aim of the study was to evaluate the effects of consumption of fillets from differently fed farmed gilthead sea bream on markers of cardiometabolic health such as platelet aggregation, circulating haemostatic markers, markers of inflammation and oxidative stress.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date February 28, 2014
Est. primary completion date November 30, 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 65 Years
Eligibility Inclusion Criteria: - Age 30-65 years old - Body Mass Index between 24-31 kg/m^2 - Habitual fish consumption: <150 g of cooked fish per week Exclusion Criteria: - Pregnancy - Current or recent weight loss effort - Use of dietary supplements - Being under treatment for any medical disorder

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Conventional fish
Participants initially randomized to this intervention arm will be provided with conventional sea bream fillets and will be asked to consume them twice weekly for 8 weeks. Conventional sea bream fillets will be produced by a fish farming company using standard procedures. Participants will also be instructed to keep the reception of prescribed medications and dietary supplements stable and not to change their lifestyle habits (e.g. other dietary habits besides fish consumption, physical activity habits or sleep habits) during the intervention. After a 6-week wash-out period (no fish consumption), participants will cross over to the other intervention arm.
Enriched fish
Participants initially randomized to this intervention arm will be provided with conventional sea bream fillets and will be asked to consume them twice weekly for 8 weeks. Conventional sea bream fillets will be produced by a fish farming company using a diet enriched with olive pomace. Participants will also be instructed to keep the reception of prescribed medications and dietary supplements stable and not to change their lifestyle habits (e.g. other dietary habits besides fish consumption, physical activity habits or sleep habits) during the intervention. After a 6-week wash-out period (no fish consumption), participants will cross over to the other intervention arm.

Locations

Country Name City State
Greece Department of Nutrition and Dietetics, School of Health Sciences and Education, Harokopio University Kallithéa Attica

Sponsors (3)

Lead Sponsor Collaborator
Harokopio University National and Kapodistrian University of Athens, Nireus Aquaculture

Country where clinical trial is conducted

Greece, 

References & Publications (1)

Ntzouvani A, Antonopoulou S, Fragopoulou E, Kontogianni MD, Nomikos T, Mikellidi A, Xanthopoulou ?, Kalogeropoulos N, Panagiotakos D. Effect of Differently Fed Farmed Gilthead Sea Bream Consumption on Platelet Aggregation and Circulating Haemostatic Markers among Apparently Healthy Adults: A Double-Blind Randomized Crossover Trial. Nutrients. 2021 Jan 20;13(2). pii: 286. doi: 10.3390/nu13020286. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline of adenosine diphosphate-induced platelet aggregation at 8 weeks Efficiency concentration fifty of adenosine diphosphate-induced platelet aggregation (microM) will be assessed by light transmittance aggregometry 0 (baseline) and 8 weeks
Primary Change from baseline of platelet activating factor-induced platelet aggregation at 8 weeks Efficiency concentration fifty of platelet activating factor-induced platelet aggregation (microM) will be assessed by light transmittance aggregometry 0 (baseline) and 8 weeks
Primary Change from baseline of thrombin-induced platelet aggregation at 8 weeks Efficiency concentration fifty of thrombin-induced platelet aggregation (microM) will be assessed by light transmittance aggregometry 0 (baseline) and 8 weeks
Primary Change from baseline in of plasminogen activator inhibitor-1 activity at 8 weeks Plasminogen activator inhibitor-1 activity (mAU/mL) will be measured in blood samples using commercially available ELISA kits 0 (baseline) and 8 weeks
Primary Change from baseline in soluble P-selectin levels at 8 weeks Soluble P-selectin levels (ng/mL) will be measured in blood samples using commercially available ELISA kits 0 (baseline) and 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05994313 - STARchy Staples: a Randomised Controlled Trial on Cardiometabolic Health N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Recruiting NCT04956003 - Optimizing Cardiometabolic Health, Cognition and Academic Performance in Children (HAPHC) N/A
Not yet recruiting NCT06348082 - Project Women's Insomnia Sleep Health Equity Study (WISHES) N/A
Completed NCT04440202 - Cardioprotective Properties of ELAIOTSIPOURA N/A
Completed NCT03204552 - Tzu Chi Health Study (Diabetes and Cardiometabolic Health Components)
Recruiting NCT05582720 - Cardioprotective Properties of Vegan Burger N/A
Completed NCT05414084 - Aggregate Metabolic Phenotypes for (Poly)Phenols: Development of an Oral (Poly)Phenol Challenge Test (OPCT) N/A
Recruiting NCT05856318 - Cardiometabolic Health in First Time Pregnancy
Recruiting NCT05718245 - HEPA, PM2.5, and Cardiometabolic Health N/A
Completed NCT03956732 - Effects of Milk Protein and Vitamin D on Children's Growth and Health N/A
Completed NCT04711928 - The Association Between Sedentary Behaviour and Cardiometabolic Health in Trained Athletes
Recruiting NCT04103346 - Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors N/A
Completed NCT04418102 - The InterSat Study N/A
Not yet recruiting NCT05057416 - The Effect of Exercise Intensity on Adherence N/A
Completed NCT02809508 - The Effect of Oily Fish and Poultry on Children's Cardiometabolic Health and Cognitive Function N/A
Active, not recruiting NCT05063929 - Impacts of Fruit on the Gut Health and Human Health N/A
Recruiting NCT06370936 - The EXPLAIN Study: Exploring Plant-Based Meat Analogues for Their Impact on Health N/A
Not yet recruiting NCT06347094 - Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols N/A
Recruiting NCT05628012 - Circadian Time Restricted Eating N/A